Sunflower Pharmaceutical Group Co.,Ltd (SHE:002737)
China
· Delayed Price · Currency is CNY 14.24
+1.14 (8.70%)
Apr 30, 2026, 9:45 AM CST
SHE:002737 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Net Income | -297.07 | 492.05 | 1,119 | 867.22 | 704.74 | Upgrade
|
| Depreciation & Amortization | 173.16 | 178.98 | 181.2 | 268.81 | 167.77 | Upgrade
|
| Other Amortization | 4.43 | 5.67 | 2.05 | 1.77 | 2.17 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.65 | 0.24 | -3.23 | -7.43 | -47.77 | Upgrade
|
| Asset Writedown & Restructuring Costs | 80.97 | 25.79 | 0.48 | 26.43 | 29.68 | Upgrade
|
| Loss (Gain) From Sale of Investments | -31.05 | -11.95 | -30.58 | 9.92 | -26.36 | Upgrade
|
| Provision & Write-off of Bad Debts | - | 7.63 | -4.6 | 1.06 | 27.05 | Upgrade
|
| Other Operating Activities | -2.24 | 47.6 | 54.88 | 39.18 | 52.53 | Upgrade
|
| Change in Accounts Receivable | 421.49 | -415.02 | 77.04 | 26.33 | 38.45 | Upgrade
|
| Change in Inventory | 229.95 | -25.49 | -241.47 | 73.5 | -152.67 | Upgrade
|
| Change in Accounts Payable | 23.14 | -634.38 | -286.2 | 662.12 | 57.9 | Upgrade
|
| Change in Other Net Operating Assets | - | 2.77 | 25.66 | 15.16 | 10.43 | Upgrade
|
| Operating Cash Flow | 574.97 | -307.48 | 889.69 | 1,975 | 865.23 | Upgrade
|
| Operating Cash Flow Growth | - | - | -54.96% | 128.30% | -26.04% | Upgrade
|
| Capital Expenditures | -96.1 | -92.79 | -149.16 | -152.9 | -118.31 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.52 | 0.33 | 4.05 | 3.98 | 0.69 | Upgrade
|
| Cash Acquisitions | - | - | - | - | -1.1 | Upgrade
|
| Investment in Securities | -492.46 | 60.53 | 147.7 | -517.45 | -790.76 | Upgrade
|
| Other Investing Activities | 35.42 | 34.47 | 33.61 | 21.94 | 19.76 | Upgrade
|
| Investing Cash Flow | -552.62 | 2.54 | 36.2 | -644.43 | -889.72 | Upgrade
|
| Short-Term Debt Issued | - | 0.02 | 14.43 | - | - | Upgrade
|
| Long-Term Debt Issued | 118 | - | - | 420 | 306.58 | Upgrade
|
| Total Debt Issued | 118 | 0.02 | 14.43 | 420 | 306.58 | Upgrade
|
| Long-Term Debt Repaid | -13 | -16.7 | -426.47 | -238.12 | -383.49 | Upgrade
|
| Total Debt Repaid | -13 | -16.7 | -426.47 | -238.12 | -383.49 | Upgrade
|
| Net Debt Issued (Repaid) | 105 | -16.68 | -412.04 | 181.88 | -76.91 | Upgrade
|
| Issuance of Common Stock | - | - | - | 22.13 | 28.01 | Upgrade
|
| Common Dividends Paid | -292.12 | -885.2 | -588.51 | -416.7 | -212.19 | Upgrade
|
| Other Financing Activities | -23.07 | -40.63 | -38.28 | -33.87 | -48.24 | Upgrade
|
| Financing Cash Flow | -210.19 | -942.51 | -1,039 | -246.57 | -309.33 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.19 | -0.3 | 0.23 | -0.02 | - | Upgrade
|
| Net Cash Flow | -188.04 | -1,248 | -112.71 | 1,084 | -333.82 | Upgrade
|
| Free Cash Flow | 478.86 | -400.27 | 740.52 | 1,822 | 746.92 | Upgrade
|
| Free Cash Flow Growth | - | - | -59.37% | 144.00% | -21.96% | Upgrade
|
| Free Cash Flow Margin | 20.66% | -11.85% | 12.99% | 35.77% | 16.74% | Upgrade
|
| Free Cash Flow Per Share | 0.82 | -0.68 | 1.27 | 3.11 | 1.28 | Upgrade
|
| Cash Income Tax Paid | 232.58 | 459.29 | 723.41 | 579.81 | 565.31 | Upgrade
|
| Levered Free Cash Flow | 658.38 | -504.18 | 349.11 | 1,537 | 698.11 | Upgrade
|
| Unlevered Free Cash Flow | 658.38 | -501.96 | 352.84 | 1,543 | 704.48 | Upgrade
|
| Change in Working Capital | 646.11 | -1,053 | -429.66 | 768.39 | -44.59 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.